Pharmaceutical manufacturers of Heparin

Aspen CDMO offers customized manufacturing services for Finished Dosage Forms across two continents: Europe and Africa. The primary dosage forms include injectables such as pre-filled syringes, liquid and lyophilized vials, BFS ampoules, and infusion bags, as well as tablets, creams, ointments, sprays, and BFS ampoules for nebulizers. It operates three advanced facilities in France.

Pfizer CentreOne® is a completely distinct global contract development and manufacturing organization (CDMO), as well as a prominent provider of specialty APIs and intermediates. Supported by resources from Pfizer, we have provided technical knowledge, regulatory assistance, and long-term supply for more than 40 years. With a network of over 35 sites spanning six continents, we are capable of securely and effectively guiding complex compounds from development to commercial manufacture. For more details, please visit http://www.pfizercentreone.com

Our objective is to pave the path to a more wholesome future. However, we are also concerned about the manner in which we collectively achieve this goal. Being a company whose products impact the well-being of individuals worldwide, we uphold ourselves to a stringent standard and anticipate others to treat us likewise. We are advocates of transparent, truthful, and principled operation with the utmost level of ethics and honesty. This encompasses ensuring the company's compliance with all relevant laws and regulations on a global scale.

Established in 1978 as a specialized facility for Small Volume Parenterals (SVPs), Gland Pharma has evolved into a forward-thinking and quality-focused organization catering to the pharmaceutical requirements of diverse global markets. The company possesses state-of-the-art facilities for injectables established in partnership with Vetter Group, Germany, providing Gland Pharma a technological advantage in injectables, particularly in Pre Filled Syringes.

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

Established in 1993, SUANFARMA is a business-to-business partner in the field of life sciences specializing in the formulation, manufacture, and marketing of components for the pharmaceutical, veterinary, and nutraceutical sectors. In SUANFARMA, we provide our CDMO capabilities for fermentation and chemical synthesis projects, delivering a comprehensive service with a proven track record, facilitating success in the formulation, expansion, production, and marketing of an API, whether it is innovative or generic

HELM AG, a company based in Hamburg and owned by a family, has a 120-year history in 4 diverse sectors: Pharmaceuticals, Chemicals, Crop Protection, and Crop Nutrition. With a global presence through subsidiaries, sales offices, and partnerships, HELM is recognized as one of the world's leading independent marketing firms for chemicals. At HELM Pharma, our goal is to establish ourselves as the top B2B project and marketing platform, offering a distinctive partnership experience. In the marketing of our products, we deliver a comprehensive range of services for our business associates.

PI Corporation is the one of top Japanese manufacturers of Active Pharmaceutical Ingredients (APIs)*, and intermediates to provide to pharmaceutical companies. We offer services in a wide range; focusing mainly in the CDMO (Contract Development and Manufacturing Organization) business of APIs and intermediates, we provide a rapid and accurate response to a variety of clients’ needs in synthetic route design, manufacturing process, pilot manufacturing /investigational medical manufacturing, and commercial manufacturing.

The Medimpex brand has been well-established for more than 60 years with a strong heritage in the pharmaceutical sector in Hungary and its international commerce. Medimpex UK has acted as the link between Hungarian pharmaceuticals and the United Kingdom as well as the Republic of Ireland, offering a dependable and well-established supply chain. As a wholly owned subsidiary of Gedeon Richter, Hungary's largest pharmaceutical manufacturer, Medimpex takes pride in upholding the finest traditions in promoting Hungarian pharmaceutical products. We are committed to marketing various products on behalf of EGIS PLC and other Hungarian suppliers in the UK.

Researching, isolating and developing new and safer biological active pharmaceutical ingredients for human use have been Opocrin’s core business since 1964. From the small Research Laboratory founded by pharmacologist Prof. Pietro Bianchini, Opocrin has become a world leader in the production of heparin derivatives and one of the biggest players in the active pharmaceutical ingredient sector.

Established in 1953, Biological E Limited is a prominent producer of human vaccines including Tetanus, DT, DTP, Td HepatitisB, DTP-HepB-Hib Pentavalent, Hib, IPV, Japanese encephalitis, Measles, and Rubella, as well as Tetanus Antitoxin and Snake Antivenin. The company has obtained WHO prequalification for Tetanus, DTPHepBHib, JE, DTP, and Td. Additionally, they produce APIs such as Noscapine Base and HCL (Alkaloids) and Heparin Sodium, along with pipeline injectables like Heparin Inj, LMWH Enoxaparin, Dalteparin, Fosaprepitant, Daptomycin, Risperidone, and Paliperidone Palmitate.

The origins of Shenzhen Hepalink can be dated back to 1986 when it was known as Chongqing Tongda Bio-product Co. With over 31 years of experience in heparin research and production, Hepalink has established itself as one of the leading suppliers of heparin sodium API globally. Employing state-of-the-art equipment, Hepalink ensures the production of the highest quality and safest products. Additionally, it serves as a supplier to well-known pharmaceutical companies worldwide. The Hepalink group utilizes the heparin sodium API platform to expand its industry chain from crude heparin to preparations, thereby contributing to the assurance of heparin quality.

We take pride in being a company where our employees can experience joy and contentment, while consistently showing appreciation and regard for our clients, suppliers, and advocates in the nearby community. Furthermore, our goal is to be an endlessly ambitious creator of products that benefit society and the environment, manufacturing them in a safe and secure manner. We don't settle for the status quo, but rather approach our work with imaginative innovation to enhance our products and management, and to increase our personal capacity. We are joined by employees who possess a sense of purpose and responsibility in all their actions and are dedicated to working with dignity.

Biofer SpA is an independent Italian company, globally recognized for the development, production and marketing of different families of APIs and committed to promoting human well-being through scientifically advanced solutions of exceptional quality.

The Panpharma Group is acknowledged for its proficiency in the advancement, manufacturing, and promotion of injectable medications for usage in medical facilities. Since its inception, Panpharma has deliberately specialized in the area of injectable drugs to emerge as one of its frontrunners. Its extensive array of specialties encompasses the primary therapeutic categories, placing a specific emphasis on antibiotic treatment. Panpharma items are produced in compliance with the most rigorous quality criteria, typically at the Group's manufacturing facilities in France and Germany.

Scientific Protein Laboratories LLC (SPL) manufactures cGMP bulk active pharmaceutical ingredients (APIs) supplied to pharmaceutical and biopharmaceutical firms globally. Key offerings comprise of heparin sodium and pancreatic enzymes. SPL stands as one of the largest autonomous suppliers of heparin sodium and pancreatic enzymes globally, with more than three decades of expertise. The company possesses proficient capabilities in the extraction and refinement of active substances.

Wanbang Biopharmaceuticals specializes in the development, production, and distribution of pharmaceuticals tailored to patients with diabetes and associated cardiovascular conditions. Its range of products encompasses animal insulin, Glimepiride tablets, Meglumine Adenosine Cyclophosphate, EPO, Bangtan (Telmisatan), and Heparin sodium. In addition, the company offers aloe compound capsules designed to promote liver-heat clearance and bowel relaxation, among other benefits.